November 19, 2015 / 7:41 AM / 4 years ago

BRIEF-Hybrigenics to present new in vitro data on inecalcitol in chronic myeloid leukemia

Nov 19 (Reuters) - Hybrigenics SA :

* To present new in vitro data on Inecalcitol in chronic myeloid leukemia (CML) at ASH conference in the United States

* Inecalcitol inhibits the proliferation in vitro of stem cells of patients with CML in synergy with Imatinib, Nilotinib or Dasatinib

* Inecalcitol alone resulted in the in vitro inhibition of the growth of CML stem cell cultures isolated from 15 out of 18 patients

* Macrophage genes specifically induced in vitro by Inecalcitol were identified as potential biomarkers predictive of the clinical response to Inecalcitol

Source text: bit.ly/1SGnGTo Further company coverage: (Gdynia Newsroom:)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below